Jeff Hermes – Biography
Last update: April 21, 2026Executive profile
Jeff was Vice President at Kallyope, and Head of Screening and Translational Enzymology at Roche. Jeff Hermes joined Odyssey Therapeutics in 2021.
Jeff Hermes is currentlyExecutive Vice President, Enabling Sciences at Odyssey Therapeutics - View - Odyssey Therapeutics org chart
Create your alert
to follow the career of Jeff Hermes.
Education
In 1988, Jeff Hermes completed a Postdoctoral Fellowship in Chemistry at Harvard University.
They have also studied at Harvard University :
Find more alumni from Harvard University
More about Jeff Hermes
Selected links
Do you need to know more about Jeff Hermes? More results.
Participate
Social media
- Jeff Hermes on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Jeff Hermes
The colleagues of Jeff Hermes
Company Colleagues
- At Odyssey Therapeutics, Jeff Hermes has 35 colleagues including Gary Glick (CEO & President), Carl Gordon (Director)…
Homonyms
- Jeffrey Hermes - Executive Vice President, Enabling Sciences - Odyssey Therapeutics
Industry Colleagues
- In the Biotechnology industry, Jeff Hermes has 35,757 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Jeff Hermes.
Get in Touch
Here are a few tips for establishing great contacts.
